BioSpace News Archive

Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will make a formal presentation at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 8:20 a.m. Eastern Time.

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, announced that a replay of its December 15, 2020 presentation and Q&A session by a panel of investors from the Annual LD Micro Main Event is now available.

SpringWorks Therapeutics, Inc. announced that Saqib Islam, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 7:30 a.m. Eastern Standard Time.

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that the company will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021.

Trial Designed to Evaluate Potential of FXR-Based Combination Therapy in a Growing Segment of NASH Patient Population with Significant Unmet Needs

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced that the company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on January 12, 2021, at 12:10 p.m. ET.

Immunic, Inc. announced management’s participation in the following investor conferences in January

Karuna Therapeutics, Inc. announced that Steve Paul, M.D., chief executive officer, president and chairman, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:50 a.m. EST.

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that Chief Executive Officer Jack Bailey will present a company update at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021 at 2:50 p.m. ET.

TELA Bio, Inc., an innovative MedTech company focused on advancing the field of soft-tissue reconstruction, announced that it has welcomed Bruce Freedman, M.D., FACS as Vice President of Clinical Development.